UBVAX (UBVAX) Stock Price & Analysis
UBVAX (UBVAX) fell 1.76% to USD 84.23 as of September 9, 2026 at 02:16 UTC, according to Nexqual real-time market data.
UBVAX last closed at USD 84.23; the session ranged USD 84.23–84.23 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 74.91–88.5 (NAS). Source: Nexqual, September 9, 2026 at 02:16 UTC.
Key Statistics (as of September 9, 2026 at 02:16 UTC)
| Price | USD 84.23 |
|---|---|
| Change | ▼ 1.76% (down) |
| Previous Close | USD 84.23 |
| Open | USD 84.23 |
| Day Range | USD 84.23 – 84.23 |
| 52-Week Range | USD 74.91 – 88.5 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (UBVAX)
Nexqual's technical model rates UBVAX "SELL" based on 2 bullish and 5 bearish signals across 127 daily candles, as of September 9, 2026 at 02:16 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 37.36 (neutral) |
| vs SMA50 | Below (USD 86.27) |
| MACD | -0.31 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UBVLX | Undiscovered Managers Behaviora | USD 87.77 | ▼ 1.58% |
| JVAAX | JPMorgan Value Advantage Class | USD 41.51 | ▼ 1.59% |
| UBVSX | Undiscovered Managers Behaviora | USD 87.24 | ▼ 1.58% |
| OIEIX | JPMorgan Equity Income Fund A | USD 28.11 | ▼ 1.13% |
| VHIAX | JPMorgan Growth Advantage Fund | USD 39.26 | ▼ 0.36% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 02:16 UTC. This page is informational and not investment advice.